Marex Group’s LENZ Therapeutics LENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$61.4K Hold
16,000
– – ﹤0.01% 1600
2026
Q2
$90.9K Hold
16,000
– – ﹤0.01% 1068
2026
Q1
$146K Hold
16,000
– – ﹤0.01% 930
2025
Q4
$256K Buy
+16,000
New +$466K ﹤0.01% 759

Other funds holding LENZ

Marex Group's LENZ Position: Q3 2026 in Review

Marex Group held its LENZ Therapeutics (LENZ) position steady in Q3 2026 at 16,000 shares worth $61.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1600.

Marex Group first reported a position in LENZ in Q4 2025 and has held it in 4 quarters since. The position peaked at $256K in Q4 2025. 138 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.

  • Marex Group held 16,000 shares of LENZ Therapeutics worth $61.4K as of Q3 2026.
  • Marex Group left its LENZ Therapeutics share count unchanged in Q3 2026.
  • LENZ Therapeutics made up ﹤0.01% of Marex Group's portfolio in Q3 2026, its #1600 holding.
  • Marex Group first reported a position in LENZ Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Marex Group's LENZ Therapeutics position peaked at $256K in Q4 2025.
  • 138 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.

Based on Marex Group's 13F filing for Q3 2026, filed 16 Nov 2026.